Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
757.370.46%
QQQ
705.530.51%
BTC/USD
76394.952.2986%
DIA
520.200.82%
GLD
392.83-
TLT
80.780.19%

Artiva Biotherapeutics Inc (ARTV) Stock Price, Quote, News & History

ARTVNASDAQ
Trade with Public
Trade with Public
$9.12
-1.02-10.06%
Last update: Sep 15, 11:30 AM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Artiva Biotherapeutics (ARTV) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$10.05
Close
-
Volume / Avg.
209.60K / 436.48K
Day Range
$9.13 - $10.05
52 Wk Range
2.22 - 14.53
Market Cap
$445.88M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
28
Short Interest
5.35%
Days to Cover
6.71

Recent Artiva Biotherapeutics Inc News

Alpha Buying: 4 Biotech Stocks a Healthcare Specialist Is Buying

Biotechnology investing is a strange corner of the market. A company can own a drug that may eventually produce billions of dollars in sales and still find itself scrambling to raise enough cash to survive another
Tim Melvin

Why Cracker Barrel Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Cracker Barrel (CBRL) stock rises in pre-market trading after reporting better-than-expected Q3 results and raising FY26 sales guidance.
Avi Kapoor

Artiva Biotherapeutics Stock Slides Despite Positive Trial Data

Artiva Biotherapeutics shares fall after Phase 2a rheumatoid arthritis data and a $300 million private placement announcement.
Vandana Singh

Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Dow futures up 250 points. Sonoco Products Co (SON) shares down 5.7% in pre-market after reporting lower-than-expected earnings and sales.
Avi Kapoor

Crude Oil Falls Over 1%; US Homebuilder Sentiment Edges Higher In December

Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-75.23M
Investing Cash Flow (TTM)
65.22M
Financing Cash Flow (TTM)
283.00M
Free Cash Flow (TTM)
-76.91M
Capital Expenditure (TTM)
-1.68M
Net Change in Cash (TTM)
272.99M

Analyst Trends and Forecast

5
May
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$156.20M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.43
Earnings Yield % (TTM)
-31.85%
Earnings Yield % (FWD)
-32.64%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$7.11

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$111.00K
Total Cash
$301.45M
Debt to Equity
0.03
Issuance of Debt (TTM)
-$111.00K
Repayment of Debt (TTM)
-$111.00K

Key Statistics

Open
$10.05
Close
-
Volume / Avg.
209.60K / 436.48K
Day Range
$9.13 - $10.05
52 Wk Range
2.22 - 14.53
Market Cap
$445.88M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
28
Short Interest
5.35%
Days to Cover
6.71

About

Sector
Health Care
Industry
Biotechnology
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the compan...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Artiva Biotherapeutics (ARTV) stock?

A

You can purchase shares of Artiva Biotherapeutics (NASDAQ:ARTV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Artiva Biotherapeutics (ARTV) competitors?

Q

What is the forecast, or price target, for Artiva Biotherapeutics (ARTV) stock?

A

Artiva Biotherapeutics has a consensus price target of $30.71.

Q

What is the current price for Artiva Biotherapeutics (ARTV)?

A

The stock price for Artiva Biotherapeutics (NASDAQ: ARTV) is $9.12 last updated September 15, 2026 at 11:30 AM EDT.

Q

Does Artiva Biotherapeutics (ARTV) pay a dividend?

A

There are no upcoming dividends for Artiva Biotherapeutics.

Q

When is Artiva Biotherapeutics (NASDAQ:ARTV) reporting earnings?

A

Artiva Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Artiva Biotherapeutics (ARTV) going to split?

A

There is no upcoming split for Artiva Biotherapeutics.

Q

What sector and industry does Artiva Biotherapeutics (ARTV) operate in?

A

Artiva Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved